rapamycin therapy

Project Summary: A double blinded randomized controlled pilot clinical trial to determine if low-dose rapamycin can improve symptoms in patients with long COVID. The trial will be performed at the Cohn Center for Recovery from Complex Chronic Illness at Mount Sinai. Blood samples obtained from...

Subsets Mean Success Until now, the heterogeneity of the patient population and the lack of a reliable biomarker to diagnose and prognose ME/CFS has thwarted clinical trials for both non-approved FDA drugs as well as repurposed agents. We have recently identified elevated levels of inactive...